Since gene therapy with adeno-associated virus system has shown promising translational potentials in HF (Eulalio et al., 2012; Gabisonia and Recchia, 2018; Ding et al., 2020), whether cardiac-specifically targeting Cerk has the therapeutic potential in ischemic heart diseases needs further investigation. The gene discussed is CERK; the disease is hydrops fetalis.